Cardioprotective effects of recombinant human erythropoietin in rats with experimental autoimmune myocarditis

Biochemical and Biophysical Research Communications

Volumn 344, Issue 3, 2006, Pages 987-994

  Mitsuma, Wataru ^a   Ito, Masahiro ^a   Kodama, Makoto ^a   Fuse, Koichi ^a   Okamura, Kazuki ^a   Minagawa, Shiro ^a   Kato, Kiminori ^a   Hanawa, Haruo ^a   Toba, Ken ^a   Nakazawa, Mikio ^b   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Tottori University   (Japan)

Author keywords

Apoptosis; Erythropoietin; Erythropoietin receptor; Experimental autoimmune myocarditis

Indexed keywords

CARDIAC MYOSIN; ERYTHROPOIETIN RECEPTOR; INTERLEUKIN 6; MESSENGER RNA; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFECT; HEART MUSCLE; HEART MUSCLE CELL; HEART PROTECTION; HISTOPATHOLOGY; IMMUNIZATION; MALE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; CARDIOTONIC AGENTS; CYTOKINES; ERYTHROPOIETIN; HUMANS; MALE; MYOCARDITIS; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

ANIMALIA;

EID: 33646148258     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.03.230     Document Type: Article

References (35)

1. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death. Circulation 99 (1999) 1091-1100 34 (2001) 199-204
2. Feldman A.M., and McNamara D. Myocarditis. N. Engl. J. Med. 343 (2000) 1388-1398
3. Kodama M., Matsumoto Y., Fujiwara M., Masani F., Izumi T., and Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin. Immunol. Immunopathol. 57 (1990) 250-262
4. Kodama M., Matsumoto Y., Fujiwara M., Zhang S.S., Hanawa H., Itoh E., Tsuda T., Izumi T., and Shibata A. Characteristics of giant cells and factors related to the formation of giant cells in myocarditis. Circ. Res. 69 (1991) 1042-1050
5. Kodama M., Matsumoto Y., and Fujiwara M. In vivo lymphocyte-mediated myocardial injures demonstrated by adoptive transfer of experimental autoimmune myocarditis. Circulation 85 (1992) 1918-1926
6. Fuse K., Kodama M., Ito M., Okura Y., Kato K., Hanawa H., Aoki S., and Aizawa Y. Polarity of helper T cell subsets represents disease nature and clinical course of experimental autoimmune myocarditis in rats. Clin. Exp. Immunol. 134 (2003) 403-408
7. Okura Y., Yamamoto T., Goto S., Inomata T., Hirono S., Hanawa H., Feng L., Wilson C.B., Kihara I., Izumi T., Shibata A., Aizawa Y., Seki S., and Abo T. Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J. Mol. Cell. Cardiol. 29 (1997) 491-502
8. Fuse K., Kodama M., Hanawa H., Okura Y., Ito M., Shiono T., Maruyama S., Hirono S., Kato K., Watanabe K., and Aizawa Y. Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis. Clin. Exp. Immunol. 124 (2001) 346-352
9. Ishiyama S., Hiroe M., Nishikawa T., Shimojo T., Abe S., Fujisaki H., Ito H., Yamakawa K., Kobayashi N., Kasajima T., and Marumo F. The Fas/Fas ligand system is involved in the pathogenesis of autoimmune myocarditis in rats. J. Immunol. 161 (1998) 4695-4701
10. Krantz S.B. Erythropoietin. Blood 77 (1991) 419-434
11. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., Itri L.M., and Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. USA 97 (2000) 10526-10531
12. Siren A.L., Fratelli M., Brines M., Goemans C., Casagrande S., Lewczuk P., Keenan S., Gleiter C., Pasquali C., Capobianco A., Mennini T., Heumann R., Cerami A., Ehrenreich H., and Ghezzi P. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. USA 98 (2001) 4044-4049
13. Junk A.K., Mammis A., Savitz S.I., Singh M., Roth S., Malhotra S., Rosenbaum P.S., Cerami A., Brines M., and Rosenbaum D.M. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 99 (2002) 10659-10664
14. Yang C.W., Li C., Jung J.Y., Shin S.J., Choi B.S., Lim S.W., Sun B.K., Kim Y.S., Kim J., Chang Y.S., and Bang B.K. Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J. 17 (2003) 1754-1755
15. Maiese K., Li F., and Chong Z.Z. New avenues of exploration for erythropoietin. JAMA 293 (2005) 90-95
16. Wright G.L., Hanlon P., Amin K., Steenbergen C., Murphy E., and Arcasoy M.O. Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury. FASEB J. 18 (2004) 1031-1033
17. Calvillo L., Latini R., Kajstura J., Leri A., Anversa P., Ghezzi P., Salio M., Cerami A., and Brines M. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc. Natl. Acad. Sci. USA 100 (2003) 4802-4806
18. Cai Z., Manalo D.J., Wei G., Rodriguez E.R., Fox-Talbot K., Lu H., Zweier J.L., and Semenza G.L. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108 (2003) 79-85
19. Bogoyevitch M.A. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection. Cardiovasc. Res. 63 (2004) 208-216
20. van der Meer P., Lipsic E., Henning R.H., Boddeus K., van der Velden J., Voors A.A., van Veldhuisen D.J., van Gilst W.H., and Schoemaker R.G. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction. J. Am. Coll. Cardiol. 46 (2005) 125-133
21. Tramontano A.F., Muniyappa R., Black A.D., Blendea M.C., Cohen I., Deng L., Sowers J.R., Cutaia M.V., and El-Sherif N. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem. Biophys. Res. Commun. 308 (2003) 990-994
22. Agnello D., Bigini P., Villa P., Mennini T., Cerami A., Brines M.L., and Ghezzi P. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res. 952 (2002) 128-134
23. Villa P., Bigini P., Mennini T., Agnello D., Laragione T., Cagnotto A., Viviani B., Marinovich M., Cerami A., Coleman T.R., Brines M., and Ghezzi P. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J. Exp. Med. 198 (2003) 971-975
24. Liu H., Hanawa H., Yoshida T., Elnaggar R., Hayashi M., Watanabe R., Toba K., Yoshida K., Chang H., Okura Y., Kato K., Kodama M., Maruyama H., Miyazaki J., Nakazawa M., and Aizawa Y. Effect of hydrodynamics-based gene delivery of plasmid DNA encoding interleukin-1 receptor antagonist-Ig for treatment of rat autoimmune myocarditis: possible mechanism for lymphocytes and noncardiac cells. Circulation 111 (2005) 1593-1600
25. Hanawa H., Abe S., Hayashi M., Yoshida T., Yoshida K., Shiono T., Fuse K., Ito M., Tachikawa H., Kashimura T., Okura Y., Kato K., Kodama M., Maruyama S., Yamamoto T., and Aizawa Y. Time course of gene expression in rat experimental autoimmune myocarditis. Clin. Sci. 103 (2002) 623-632
26. Elnaggar R., Hanawa H., Liu H., Yoshida T., Hayashi M., Watanabe R., Abe S., Toba K., Yoshida K., Chang H., Minagawa S., Okura Y., Kato K., Kodama M., Maruyama H., Miyazaki J., and Aizawa Y. The effect of hydrodynamics-based delivery of an IL-13-Ig fusion gene for experimental autoimmune myocarditis in rats and its possible mechanism. Eur. J. Immunol. 35 (2005) 1995-2005
27. Adams D.H., and Lloyd A.R. Chemokines: leucocyte recruitment and activation cytokines. Lancet 349 (1997) 490-495
28. Yoshida T., Hanawa H., Toba K., Watanabe H., Watanabe R., Yoshida K., Abe S., Kato K., Kodama M., and Aizawa Y. Expression of immunological molecules by cardiomyocytes and inflammatory and interstitial cells in rat autoimmune myocarditis. Cardiovasc. Res. 68 (2005) 278-288
29. Futamatsu H., Suzuki J., Mizuno S., Koga N., Adachi S., Kosuge H., Maejima Y., Hirao K., Nakamura T., and Isobe M. Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ. Res. 96 (2005) 823-830
30. Friedman B.J., Grinberg O.Y., Ratcliffe N.R., Swartz H.M., and Hickey W.F. Acute hemodynamic and coronary circulatory effects of experimental autoimmune myocarditis. Heart Vessels 13 (1998) 58-62
31. Wencker D., Chandra M., Nguyen K., Miao W., Garantziotis S., Factor S.M., Shirani J., Armstrong R.C., and Kitsis R.N. A mechanistic role for cardiac myocyte apoptosis in heart failure. J. Clin. Invest. 111 (2003) 1497-1504
32. Felker G.M., Adams Jr. K.F., Gattis W.A., and O'Connor C.M. Anemia as a risk factor and therapeutic target in heart failure. J. Am. Coll. Cardiol. 44 (2004) 959-966
33. Silverberg D.S., Wexler D., Sheps D., Blum M., Keren G., Baruch R., Schwartz D., Yachnin T., Steinbruch S., Shapira I., Laniado S., and Iaina A. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J. Am. Coll. Cardiol. 37 (2001) 1775-1780
34. Silverberg D.S., Wexler D., Blum M., Keren G., Sheps D., Leibovitch E., Brosh D., Laniado S., Schwartz D., Yachnin T., Shapira I., Gavish D., Baruch R., Koifman B., Kaplan C., Steinbruch S., and Iaina A. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J. Am. Coll. Cardiol. 35 (2000) 1737-1744
35. Fiordaliso F., Chimenti S., Staszewsky L., Bai A., Carlo E., Cuccovillo I., Doni M., Mengozzi M., Tonelli R., Ghezzi P., Coleman T., Brines M., Cerami A., and Latini R. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 102 (2005) 2046-2051